Showing results (221-230 of 879) with videos related to
Sort By:
Pageof 88
Anticancer Research|May 5, 1999
Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphateD J Chaplin, G R Pettit, S A HillBritish Journal of Cancer|August 1, 1993
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing timeD J Chaplin, M R Horsman, D W SiemannThe British Journal of Radiology|February 1, 1997
Nicotinamide reduces tumour interstitial fluid pressure in a dose- and time-dependent mannerC E Peters, D J Chaplin, D G HirstAnticancer Research|May 17, 2002
Influence of hypoxia and tumour-conditioned medium on endothelial cell adhesion molecule expression in vitroMargaret E Watts, Charles S Parkins, David J ChaplinCancer Investigation|September 6, 2017
Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat CancerD W Siemann, D J Chaplin, M R HorsmanBiomedica Biochimica Acta|January 1, 1989
Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapyD J Chaplin, B D Acker, M R HorsmanBritish Journal of Cancer|January 1, 1991
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivoD J Chaplin, M R Horsman, D S AokiInternational Journal of Radiation Oncology, Biology, Physics|September 1, 1987
Cytotoxicity of RSU 1069 in spheroids and murine tumorsP L Olive, R E Durand, D J ChaplinCancer Research|March 5, 2003
The first international conference on vascular targeting: meeting overviewPhilip E Thorpe, David J Chaplin, David C BlakeyJournal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|October 1, 1987
Emericella nidulans in a maxillary sinus fungal massR G Mitchell, A J Chaplin, D W MackenziePageof 88